Human coronavirus OC43 (HCoV-OC43) belongs to the genus Betacoronavirus and is one of seven known coronaviruses that can infect humans. Similar to other common cold viruses, it is primarily transmitted through respiratory droplets and close contact with infected individuals. Transmission occurs through inhalation of aerosolized particles or contact with contaminated surfaces, followed by self-inoculation of the mucous membranes. After entering upper respiratory epithelial cells, HCoV-OC43 binds to host cell receptors (such as HLA class I histocompatibility antigens or sialic acid) via its spike (S) glycoprotein. The virus then undergoes endocytosis, releasing its RNA genome into the cytoplasm to initiate replication. While HCoV-OC43 infection is typically mild, causing only runny nose, sore throat, and cough, severe cases (particularly in immunocompromised individuals or those with underlying medical conditions) can lead to lower respiratory tract infections such as bronchitis or pneumonia.
HCoV-OC43 has a characteristic coronavirus structure, with a lipid bilayer envelope studded with viral glycoproteins: spike (S), membrane (M), and envelope (E). The S protein forms the crown-like protrusions that mediate host cell attachment and membrane fusion, while the M and E proteins are essential for virion assembly and budding. Within the envelope lies a helical nucleocapsid, composed of the nucleocapsid (N) protein tightly bound to a single-stranded, positive-sense RNA genome. The HCoV-OC43 genome, approximately 30.7 kilobase pairs in length, is one of the largest genomes among RNA viruses and encodes 16 nonstructural proteins (nsp1-16), four structural proteins (S, E, M, N), and several accessory proteins. The 5′-terminal two-thirds of the genome contains open reading frames 1a and 1b (ORF1a/ORF1b), which are translated into polyproteins and subsequently cleaved by the viral protease to form the replication-transcription complex (RTC). The 3′-terminal one-third encodes structural and accessory genes, interspersed with regulatory sequences. Notably, HCoV-OC43 has a high genetic similarity to bovine coronavirus (BCoV), suggesting that it originated from a zoonotic infection and was transmitted across species.
Seasonal coronaviruses, like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cause severe respiratory symptoms in only a small subset of infected individuals. However, host factors that determine differential responses to coronavirus infections remain unclear. Here, researchers used seasonal human coronavirus OC43 (HCoV-OC43) infection as an asymptomatic model that triggers both innate and adaptive immune responses in mice. Interestingly, innate sensing pathways and adaptive immune cells were not essential for protection against HCoV-OC43. Instead, deficiency in mouse alveolar macrophages (AMΦ) resulted in severe COVID-19-like pneumonia after HCoV-OC43 infection, with massive neutrophil infiltration, neutrophil extracellular trap (NET) release, and excessive production of proinflammatory cytokines. Mechanistically, AMΦ efficiently phagocytosed HCoV-OC43, effectively blocking viral transmission, while in the absence of AMΦ, HCoV-OC43 triggered Toll-like receptor (TLR)-dependent chemokine production, leading to pneumonia. These findings reveal a central role for AMΦ in protection against seasonal HCoV-OC43 and have clinical implications for coronavirus infection-associated human immunopathology.
There was no difference in the induction of Tnfa, Il1b, and Il6 in mice treated with activated and inactivated HCoV-OC43 (Figure 1A), indicating that the induction of inflammatory genes is independent of signaling triggered by viral RNA. Next, the researchers investigated the role of cell surface PRRs TLR2 and TLR4 by using TLR2 (C29) and TLR4 (resatorvid) inhibitors in in vitro culture. Treatment with C29, but not resatorvid, significantly reduced HCoV-OC43-induced Tnfa, Il1b, and Il6 in mouse BMDM and human PBMC (Figures 1A and 1B), indicating that the induction of inflammatory genes is dependent on TLR2 signaling. To confirm the role of TLR2, the researchers induced bone marrow mesenchymal stem cells (BMDM) using bone marrow from wild-type (WT), Tlr2-/-, and Tlr4-/- mice and co-cultured them with inactivated or activated HCoV-OC43. Tlr2 deficiency blocked virus-induced Tnfa, Il1b, and Il6 (Figure 1C), but Tlr4 deficiency did not. Tlr2 deficiency also consistently blocked p65 phosphorylation and IκBα degradation in BMDMs induced by both inactivated and activated HCoV-OC43. These results strongly suggest that non-nucleic acid components of HCoV-OC43 induce transcription of inflammatory genes by activating TLR2.
Figure 1. TLR2 signaling pathways are not required for protecting mice from severe symptoms in response to HCoV-OC43. (Zhong X, et al., 2025)
Customer Reviews
A trusted choice!
The product quality was exceptional – fully inactivated yet antigenically potent. It allowed us to rapidly test and optimize protocols for inactivation detection and antibody neutralization in a BSL-2 setting before moving to BSL-3 pathogens.
Write a Review